Clinical Trials Browser

Non Small Cell Lung Cancer NSCLC × Clear all

NCT07169708 2026-05-20

A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)

Non Small Cell Lung Cancer NSCLC

NCT03164616 2026-03-13

POSEIDON

Phase 3 Active not recruiting

1,186 enrolled 26 charts 1 FDA

Non Small Cell Lung Cancer NSCLC

NCT07338396 2026-01-13

A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients

Not yet recruiting

Non Small Cell Lung Cancer NSCLC

NCT06680050 2025-12-18

AUSTRAL

Phase 2 Recruiting

Non Small Cell Lung Cancer NSCLC

NCT07188480 2025-09-23

The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients

Phase NA Recruiting

Non Small Cell Lung Cancer NSCLC

NCT07087223 2025-07-25

Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure

Phase 1/2 Recruiting

Non Small Cell Lung Cancer NSCLC